Abstract | After more than two decades of rising rates, in recent years the total kidney cancer incidence worldwide has shown signs of stabilizing, or even decreasing. In adults, kidney cancer consists of renal cell carcinoma (RCC), the predominant form, and renal transitional cell carcinoma (RTCC); these types primarily arise in the renal parenchyma and renal pelvis, respectively. Although temporal trends by kidney cancer type are not well established worldwide, incidence of RCC in the US has continued to rise, mainly for early-stage tumors, while that of RTCC has declined, and total kidney cancer mortality rates have leveled. Stabilization of kidney cancer mortality rates has also been reported in Europe. These trends are consistent with reports of increasing incidental diagnoses and a downward shift in tumor stage and size in clinical series. The changing prevalence of known risk factors for RCC, including cigarette smoking, obesity, and hypertension, is also likely to affect incidence trends, although their relative impact may differ between populations. Accumulating evidence suggests an etiologic role in RCC for physical activity, alcohol consumption, occupational exposure to trichloroethylene, and high parity among women, but further research is needed into the potential causal effects of these factors. Genetic factors and their interaction with environmental exposures are believed to influence risk of developing RCC, but a limited number of studies using candidate-gene approaches have not produced conclusive results. Large consortium efforts employing genome-wide scanning technology are underway, which hold promise for novel discoveries in renal carcinogenesis.
Introduction
the kidney is an essential organ that maintains the homeostatic balance of fluids and solutes in the human body, and removes waste products from the blood. it also helps to regulate blood pressure, and secretes several hormones. the kidney is composed of a parenchyma and a collecting system. the parenchyma includes an outer cortex and an inner medulla, and is composed primarily of nephrons, functional filtering units consisting of glomeruli and tubules, which are lined by glandular cells. the collecting system includes the renal pelvis and calyces, which are lined by transitional cells.
adult kidney cancers that arise in the renal parenchyma are mainly adenocarcinomas, also known as renal cell carcinomas (rCCs), while those that arise from the collecting system are mainly transitional cell carci nomas. rCC accounts for more than 90% of adult kidney carci nomas (table 1; surveillance epidemiology and end results [seer] data). 1 renal transitional cell carcinoma (rtCC) arises in the renal pelvis, and comprises less than 10% of histologically confirmed kidney carcinoma. in children, the major type of kidney cancer is nephro blastoma (wilms tumor), which comprises approximately 1.2% of all kidney cancers. the majority of renal cell adenocarcinoma is of the clear cell subtype, followed by rCC not otherwise specified, papillary, and chromophobe subtypes (table 1) . although histologic subtypes of rCC have been shown to differ in clinical features and genetic determinants, 2, 3 epidemiologic data on rCC subtypes are sparse and have not revealed consistent incidence or risk factor patterns.
in this review, we will focus on adult kidney carcinoma, which is comprised of rCC and rtCC, evaluating the descriptive data and risk factor patterns both internationally and in the us. we will conclude by discussing risk factors for development of both rCC and rtCC, including new research involving genetic factors.
east Cancer surveillance network. rCC incidence among females also varies geographically, but the rates are approximately half those among males across all regions. Compared with other european regions, rtCC incidence was not elevated in Croatia and serbia. these countries are located in a region where Balkan nephropathy, a chronic interstitial kidney disease known to increase the risk of renal pelvis and ureteral cancers, is endemic. 5 Despite this, Balkan nephropathy seems to have a relatively small impact on the overall occurrence of rtCC. Worldwide, kidney cancer incidence has increased since the late 1970s, until ■ the mid-1990s when it leveled or declined in many countries
In the US, RTCC incidence has decreased while RCC incidence has increased ■ -much of this rise is due to the increasing diagnosis of early-stage tumors Cigarette smoking, obesity and hypertension are well-established risk factors ■ for RCC Genetic factors might also influence RCC risk; ongoing large consortium ■ studies promise to identify novel etiologic and prognostic factors for RCC in the us, rCC incidence differs among racial and ethnic populations (table 2) . 4 rates are lowest among populations of asian or Pacific island descent, mirroring the rates of their countries of origin. the rCC rates among white Hispanics in the us are, however, much higher than those reported in latin america, suggesting that environmental exposure could have a role in the development of the disease.
in general, rtCC incidence rates are much lower than those for rCC (table 2) . there are no clear regional differ ences in incidence patterns, although the rates seem to be lowest in latin america. men in certain countries, such as Japan (Hiroshima) and the Czech republic, seem to have a particularly high rtCC incidence, but the reason is unclear. in the us, rtCC incidence among nonHispanic white individuals is higher than among the other racial and ethnic groups, including white Hispanics. male:female rate ratios for rtCC also vary between populations, being 2:1 or lower in the majority of countries. this male:female 2:1 ratio contrasts with the ratio of almost 4:1 for bladder cancer, 6 a tumor that is also mostly of transitional cell type and thought to share common risk factors with renal pelvis cancer. this observa tion suggests that these two malignancies might have diverse etiologies.
Temporal trends
Data that allow the separate evaluation of rCC and rtCC trends internationally are limited, as until recently most registries did not report histologic type-specific data. 7, 8 on the basis of the us experience, histologic data are necessary to accurately classify kidney carcinoma as rCC or rtCC. 9 if only anatomic site codes are used, as many as 17% of rtCC cases reported to the seer regi stries would be classified as renal parenchyma cancer or kidney cancer not otherwise specified, rather than as renal pelvis cancer.
in general, total kidney cancer incidence rose from the 1970s until the mid-1990s, when it leveled or dropped in many registries. this pattern is particularly noticeable across europe, as illustrated by selected regis tries shown in Figure 1 .
4,10 leveling of kidney cancer incidence is also shown in registries in other regions, including north america (Canada: alberta, British Columbia; us: seer white and black males), oceania (new Zealand; australia: new south wales females), and asia (China: Hong Kong; singapore: Chinese males; Japan: Hiroshima females). 4, 10 this decline in incidence seems to have started earlier in some countries, including Canada, sweden, and Hong Kong. this leveling of kidney cancer incidence was consistent with patterns reported in other european countries, such as Finland, Denmark, and slovenia. (Figure 2 ), has risen consistently over time, with larger and more-rapid increases among the black than white population. rates of rtCC in the us, however, have leveled or even declined.
limited reports from cancer registries that provided long-term incidence data separately for rCC and 12 a recent report from Denmark showed that kidney cancer incidence rates (including renal pelvis cancer) rose between 1944 and 1973, after which they leveled. Compared with overall kidney cancer incidence, increases in renal pelvis and ureteral cancers were moresubstantial between 1944 and 1988, after which rates started to fall. 13 this report did not, however, use histology to classify renal carcinoma subtype, which could lead to an underestimation of rtCC incidence.
in contemporary practice, cases of rCC are being diagnosed at an earlier stage, and a general shift has similarly occurred towards smaller tumor size at diagnosis among stage i (localized) tumors.
14 incidental diagnoses of small tumors have also been documented and are attributed to the widespread use of abdominal imaging procedures for diagnostic work-up, in most cases probably to examine other abdominal disorders. 15 the stage-specific trends in rCC incidence in the us support the observation that rCC is being diagnosed at an earlier stage, with marked increases in incidence over time seen only in tumors that were localized at diagnosis (Figure 3) . 11 when tumor size was examined, the rate of f o C u S o n k I D n E y C A n C E r increase in the incidence of tumors <2.0 cm far outpaced that of tumors of larger sizes. 16 more-modest increases in incidence, however, were also observed for tumors of larger size, while the incidence of tumors of undetermined size declined, again probably due to improved diagnostic work-up and documentation of tumor size. the diagnosis of rCC at an increasingly early stage and small size might have contributed to the recent leveling of kidney cancer mortal ity rates in the us (Figure 2b ) 17 and many countries in europe. 8 us seer registry data, however, show that survival of patients with rCC across all disease stages has improved over time, suggesting a general improvement in early detection and management of these patients. 16 Risk factors renal transitional cell carcinoma Because of its rarity, rtCC has not been examined extensively in epidemiologic studies. information on risk factors for rtCC is derived mainly from case-control studies conducted during the 1980s and early 1990s, 18 in which the exposure to risk factors of patients diagnosed with rtCC was compared with an equivalent group of control subjects without cancer. in general, cases in these studies were defined by cancer anatomic site rather than morphologic classifications. Data from these studies, along with further clinical and laboratory data, provided convincing evidence that cigarette smoking and use of phenacetin-containing analgesics increase the risk of developing rtCC. [18] [19] [20] [21] in two of the largest case-control studies on renal pelvis cancer, smokers were reported to have an elevated risk of double or triple that among nonsmokers, and the risk among current smokers was approximately twice as high as in former smokers. 22, 23 this risk further increased with increasing number of cigarettes smoked and years of smoking, and was reduced with years of smoking cessation.
analgesic mixtures containing phenacetin have been classified by the international agency for research on Cancer (iarC) as a Group 1 carcinogen, with sufficient f o C u S o n k I D n E y C A n C E r evidence for an increased risk of urothelial carcinoma in humans. 20 Phenacetin alone was classified as a Group 2a probable carcinogen, because exclusive use of phenacetin in humans was uncommon, making it difficult to separate the effect of phenacetin from that of other active ingredients in a formula, as well as from the use of other analgesic preparations. since the late 1960s, phenacetin use has been phased out in most industrialized countries, and it was eventually banned from most worldwide markets in the late 1970s to mid-1980s. acetaminophen (paracetamol) is a primary metabolite of phenacetin. 24 Heavy use of this drug has been linked to end-stage renal disease and rtCC in casecontrol studies, but the evidence is inconclusive. 18 ,25 a population-based cohort study of acetaminophen users in Denmark based on linkage of prescription database and cancer registry incidence data reported a nonsignificant increase in risk of developing combined renal pelvis-ureteral cancers. 26 recent reports indicate a substantial decline in the prevalence of analgesic nephropathy among autopsy subjects between 1980 and 2000, 27 and no evidence of analgesic nephropathy in patients with end-stage renal disease who had high use of nonphenacetin analgesics. 28 these observations, therefore, do not support a role for non-phenacetin analgesics in the development of end-stage renal disease and related risk of developing rtCC.
an increased occurrence of urothelial carcinoma, including rtCC, has been observed among patients with a rapidly progressive form of nephropathy after ingestion of a Chinese nephrotoxic herb contaminant. 29 this form of nephropathy has a pattern of interstitial fibrosis similar to that of Balkan endemic nephropathy, a known risk factor for renal pelvis cancer. 5, 7 ecologic studies have linked high levels of arsenic in drinking water to kidney cancer mortality.
30-32 studies of cancer incidence using histologic data have shown that the increased incidence of kidney cancer was mainly due to rtCC. 33, 34 ecologic studies conducted in low-exposure areas, however, have detected no increase in kidney cancer incidence or mortal ity, [35] [36] [37] [38] although a link with kidney diseases has been reported. 36 other risk factors, including hypertension and kidney and ureteral stones, have been suggested, but their associa tions with rtCC development have not been demonstrated consistently. [39] [40] [41] Data on Bmi and dietary practices are limited for rtCC and do not suggest any association. 18, 41, 42 equally inconclusive are data linking risk of rtCC development to occupation, based on a small number of studies. 18, 43 renal cell carcinoma Despite the proximity in anatomic site of origin, risk factors for development of rCC are generally different from those for rtCC. an exception is cigarette smoking, which is an established risk factor for both tumor types. a number of predisposing conditions, including obesity and hypertension, are known to increase the risk of rCC development (table 3) . an elevated rCC risk has also been observed for individuals with a history of diabetes mellitus, but the effect of this disease is difficult to separate from that of obesity and hypertension. evidence is also accumulating, although not yet conclusive, to suggest an association between development of rCC and other factors, such as physical activity, alcohol consumption, occupational exposure to trichloroethylene, and parity in women. most of the initial leads to these suggested risk factors have been provided by case-control studies, 18 and results from cohort studies are increasingly being published as sufficient numbers of patients with rCC are accumulated. as the exposure data and biological samples for molecular analyses in cohort studies are collected before cancer diagnosis, results from these investigations are less prone to recall bias and are unaffected by the cancer and its treatment. when possible, this review of rCC risk factors draws on recent results from cohort studies and pooled analyses. some results from case-control studies also are included when they are complementary to the cohort results.
Cigarette smoking
Cigarette smoking is considered a causal risk factor for rCC by the iarC and the us surgeon General. 21, 44 Compared with people who have never smoked, the risk of developing rCC is increased by approximately 50% in male and 20% in female smokers. 45 a clear doseresponse pattern of risk was observed with increasing number of cigarettes smoked. smoking cessation alleviates this risk, but only among long-term quitters of 10 or more years. 16, 45 the overall prevalence of cigarette smoking in developed countries has declined over time, while it has remained stable or increased in developing countries. 46 For example, the total annual consumption of manufactured cigarettes peaked in 1963 in the us, 1976 in Denmark, 1985 in italy, and 1980 in australia. 47 these patterns suggest that the relative importance of cigarette smoking in the development of kidney cancer might rise in developing countries, while declining in developed regions.
Cigarette smoking is hypothesized to increase the risk of rCC through chronic tissue hypoxia resulting from carbon monoxide exposure, and via smoking-related disorders such as chronic obstructive pulmonary disease. 48 in addition, peripheral blood lymphocyte samples from patients with rCC showed greater Dna damage than samples from control participants after treatment with a tobacco-specific N-nitrosamine (nnKoac), and rCC risk increased with increasing levels of Dna damage in the nnKoac-treated lympho cytes in a case-control comparison after adjusting for differences in smoking status and other confounding factors. 49 these observations suggest that increased sensi tivity to nicotinederived nitrosamine ketone (nnK) in cigarette smoke may predispose susceptible individuals to elevated rCC risk. Deletions in chromo some 3p, a frequent site of genetic alterations in rCC, were also more common in cultured peripheral blood lymphocyte cells from patients with rCC than in those from control subjects after the cells from both groups were treated with benzo[α]pyrene diol epoxide (BPDe), a metabolic product of the major cigarette smoke constituent benzo[α]pyrene. 50 these data suggest that BPDe sensitivity in chromosome 3p may reflect genetic susceptibility to rCC, and that exposure to tobacco smoke might increase rCC risk in susceptible individuals. Obesity excess body weight was estimated to have a role in the development of more than 40% of rCC cases in the us, and more than 30% in europe, based on estimates of rCC risk associated with overweight and obesity, and the prevalence of these conditions among us and european populations during the 1980s and 1990s. 51 Prospective studies conducted worldwide found that individuals who were overweight or obese at baseline had an increased risk of subsequent rCC, in a doseresponse manner, [52] [53] [54] [55] by 24% for men and 34% for women for every 5 kg/m 2 increase in Bmi. 56 waist-tohip ratio, weight cycling, and weight gain during adulthood have also been associated with increased risk of rCC, but their impact is difficult to disentangle from the effects of Bmi. 16 the prevalence of obesity has increased markedly, not only in high-resource regions, such as the us and western europe, but also in low-income and middleincome countries. 57 Comparable long-term international data on obesity prevalence are limited, 58 although it has been reported that the rise in overweight and obesity seems to be faster in lower income countries since the 1970s. 59 in the us, the age-adjusted prevalence of obesity has not increased significantly among women since 1999, and among men since 2003. 60 the global rise in obesity is likely to have contributed to the increase in rCC incidence. However, it is probably too soon for the recent stabilizing obesity prevalence in high-resource countries to have had a substantial impact on current rCC trends, given the long latent period of cancer development. several mechanisms might explain the increased risk of rCC development in obese individuals. these mechanisms include chronic tissue hypoxia, insulin resistance and compensatory hyperinsulinemia, altered endocrine milieu and production of adipokines, obesityinduced inflammatory response, and lipid peroxidation and oxidative stress; however, direct evidence for these mechanisms in humans is limited. 61 
Hypertension
Hypertension is a major chronic disease with increasing prevalence, which affects approximately 20-40% of the world's population. 62, 63 uncontrolled hyper tension can lead to chronic kidney disease, worsening renal function, and enhancing progression to end-stage renal disease, conditions that may predispose to the development of rCC. the extent to which the rising prevalence of hypertension might have contributed to increasing rates of rCC is difficult to estimate, owing to differences between populations in the awareness and effectiveness of hypertension control and other contributing risk or protective factors.
although uncommon, cancer cells in some rCCs can produce renin, leading to hypertension through its effect on the renin-angiotensin system, which has a central role in blood pressure regulation. 64 Hypertension has also been reported in a small percentage of patients with advanced rCC treated with sorafenib, a potent angiogenesis inhibitor.
sufficient evidence exists to demonstrate that hypertension predisposes to development of rCC. a number of studies have reported an association between development of rCC and a history of long-term hypertension, and cohort studies with blood pressure measurements taken at baseline generally report a dose-response associa tion of increasing rCC risk with rising blood pressure. 41, [66] [67] [68] users of diuretics and other antihypertensive medications also have an elevated risk of rCC, but an effect of these agents independent from that of hypertension per se has not been established. [68] [69] [70] [71] [72] in a swedish cohort study with sequential blood pressure measurements, rCC risk increased with elevation of blood pressure and decreased with reduction in blood pressure over time, 41 indicating a tumor-promoting effect of hyper tension, and that effective control of blood pressure might reduce rCC risk.
Despite the strong relationship between obesity and hypertension, these disorders seem to be independently associated with risk of rCC. rCC risk is higher among individuals who are both obese and hyper tensive than among patients who have only one of these dis orders. 41, 68, 71 the biological mechanisms underlying the association between hypertension and rCC are unclear, but might include chronic renal hypoxia and lipid peroxidation with formation of reactive oxygen species.
48,73
Other pre-existing disorders a history of diabetes mellitus has been linked to an increased risk of developing rCC in cohort studies, but a role independent from those of obesity and hypertension has not been conclusively demonstrated. 66, 69, 71, 74 the associa tion between elevated rCC risk and diabetes history was not significant after adjustment for hypertension and Bmi in some studies; 66, 69, 71 another study inadequately adjusted for the effect of hypertension and is, therefore, inconclusive. 74 an increased risk of rCC has been reported in patients with end-stage renal disease who are on long-term hemodialysis, as well as after renal transplantation. 75, 76 Kidney transplant recipients are also more likely to have subsequent rCC diagnosed in the native kidney than in the transplanted kidney. 77 evidence suggests an increased risk of rCC in patients with acquired renal cystic disease. 78 an elevated risk of primary rCC has also been reported among cancer survivors, 79 and in one study the risk of metachronous bi lateral rCC increased steadily with younger age at diagnosis of the first cancer. 80 the heightened clinical surveillance in these patient groups, however, might contribute to the more-frequent diagnosis of a subsequent rCC.
Reproductive and hormonal factors an increased risk of rCC has been associated with increasing parity among women in several cohort studies, [81] [82] [83] [84] although not all studies support this observation. 85 Compared with nulliparous women, rCC risk increased 40-90% among women who had given birth, 81, 82, 84 and rose with increasing number of births. [81] [82] [83] [84] an inverse association with maternal age at first birth has also been reported, with the highest risk among women who had four or more births before the age of 26 years. 84 the mechanisms underlying this observed association of rCC with parity are unclear, although pregnancyinduced hypertension and renal stress might have a role. associations of rCC with other reproductive factors, including the use of oral contraceptives and hormone replacement therapy, are not consistently observed. 16 Physical activity regular physical activity is associated with a reduced risk of several types of cancer, particularly colon and breast cancers. 86 Data linking physical activity to rCC risk are still limited, but most studies examining this issue have reported a lowering of risk with higher level of physical activity. 66, 71, [87] [88] [89] several cohort studies have reported a dose-response pattern of reduction in rCC risk with increasing levels of activity, assessed by current exercise, routine physical activity, recreational activity, or energy expenditure in a typical day. 71, 88, 89 Physical activity has been shown to reduce body weight and blood pressure, improve insulin sensitivity, and reduce chronic inflamma tion and oxidative stress; 86, [90] [91] [92] all these changes could contribute to a reduction in rCC risk.
Diet nutrition is an important determinant of growth, body function, and immune defense. overconsumption or deficiency in certain dietary constituents has been linked to a variety of diseases, including cancer. 57 Diets rich in fruits and vegetables were associated with a low risk of rCC in a pooled analysis of cohort studies, 93 but the reported association of antioxidant nutrients such as vitamins a, C and e, and carotenoids with the disease is variable. [94] [95] [96] [97] although high consumption of fat and protein, particularly of animal origin, is a potential risk factor, a pooled analysis of cohort studies and the results from a large multicenter european cohort study revealed no association between intake of these macronutrients and rCC in multivariate models.
98-100 the role of processed meat, however, might warrant further investiga tion, as a weak association with rCC was observed among individuals with the highest intake (≥27 g/day), even after adjustment for known rCC risk factors.
98,100 selfreported dietary caloric consumption is not associated with rCC risk; 99, 101 however, a positive association was observed with rCC once potential systematic bias in selfreported caloric intake was removed by calibration using a doubly-labeled water protocol. the inclusion of Bmi in the dietary model reduced the association with caloric intake to a nonsignificant level, indicating that these two factors are highly correlated. 101 this observa tion further suggests that evaluation of cancer risk should consider the overall picture of energy balance, encompassing both energy intake and output through physical activity, as well as Bmi.
the chemical acrylamide is used in producing glues, paper and cosmetics, and to produce poly acrylamide, which is used in the treatment of drinking and waste water. acrylamide is naturally produced when starch-rich r E V I E W S food is cooked at high temperatures. it is classi fied by the iarC as a probable human carcinogen, 102 and has been detected at unexpectedly high levels in common fried and baked foods. 103 epidemiologic studies assessing the link between acrylamide and rCC risk, however, have yielded mixed results. 16, 104 two case-control studies in sweden found no association with rCC, with risk estimates of 1.0-1.1 (odds ratio [highest versus lowest quartile]). 105, 106 By contrast, a study in a Dutch cohort reported a statistically significant 60% increase in risk among indivi duals in the highest quintile of acrylamide intake (mean 40.8 μg/day) compared with those in the lowest quintile (mean 9.5 μg/day). 107 Given the ubiquity of acrylamide in foods, monitoring its carcinogenic potential in humans through existing studies might be prudent. alcohol consumption has been inversely associated with rCC risk in a dose-response manner in prospective studies, with an estimated 28% reduction in risk among individuals who consumed at least 15 g of alcoholequivalent to slightly more than one alcoholic drink-per day. 108 this inverse association was observed for all types of alcoholic beverage, including beer, wine, and spirits. By contrast, no association was found between rCC and total fluid intake from all beverages or individual types of beverage, including coffee, tea, milk, juice, soda, and water. 109 Occupation and environment rCC is not generally considered an occupational disease, but associations with certain occupations and related exposure to some industrial agents have been reported. trichloroethylene (tCe), considered a probable human carcinogen by the iarC, 110 is by far the most extensively examined chemical in relation to rCC risk. widely used as a metal degreaser and chemical additive, tCe has also become a common environmental contaminant. 111 epidemiologic evidence linking tCe to rCC is accumulating, with a large number of studies reporting an increase in risk with increasing levels of exposure. 112, 113 this association has been found using a variety of study designs and exposure-assessment methods, in different populations and various settings. the observation of this finding across diverse studies increases the likelihood of a true association. the difficulties in determining the mode of action and the complexities of tCe pharmacokinetics, co-exposure to other solvents, and various other study limitations, such as small number of exposed subjects and inadequate adjustment for confounding factors, however, have precluded the establishment of a causal association to date. [111] [112] [113] [114] at high levels of exposure, heavy metals such as cadmium, lead, and arsenic are known to be nephrotoxic. environmental exposure to low levels of these metals, as measured by blood and urine markers, has also been associated with hypertension and indicators of kidney disease.
115-118 studies of occupations that may have exposure to these agents, such as metal workers, printers, and oil refinery workers, have suggested associations with rCC risk, but these associations have not been consistently observed. 16, 18 such studies that are based only on job title and industry of employment are limited by the lack of specific exposure information.
Genetic susceptibility inherited rCC is known to occur in a number of familial cancer syndromes, most notably in von Hippel-lindau (vHl) disease. this disease is characterized by alterations in the VHL gene and predisposition to a number of disorders among family members, including the clear cell subtype of rCC. 119 only a very small proportion of patients with rCC are from families with these rare syndromes, although the exact frequency is difficult to pinpoint. a familial predisposition has, however, been demonstrated in sporadic cases of rCC; a recent metaanalysis demonstrated that the risk of rCC was more than doubled among individuals who had a first-degree relative diagnosed with kidney cancer. 120 the interplay between exposure to environmental risk factors and the genetic susceptibility of exposed individuals is believed to influence the risk of developing sporadic rCC. studies of signature tumor Dna alterations may provide clues to relevant environmental carcinogen exposures. 121 VHL mutations in rCC have previously been linked to heavy f o C u S o n k I D n E y C A n C E r tCe exposure, 122 but this finding has yet to be replicated in other occupational studies; 123 recent advances in tumor array technology and high throughput scanning and sequencing techniques will potentially enhance the opportunities for such discoveries. 124, 125 a 2003 study demonstrated shorter telomere length in peripheral blood lymphocyte Dna in patients with rCC compared with control subjects, an association that seemed to be modified by cigarette smoking. 126 shortened telomeres might lead to chromosomal abnormali ties and serve as one of the initiating steps in carcino genesis; this study was the first to demonstrate a relationship between telomere dysfunction and rCC risk. another study indicated that low mitochondrial Dna (mtDna) content in peripheral blood lymphocytes was associated with elevated risk of rCC in a dose-response manner. 127 although lymphocyte mtDna content was significantly lower among smokers than nonsmokers in this study, smoking did not modify the association between mtDna and rCC risk. Both telomere length and mtDna content may potentially assist in understanding rCC carcinogenesis, but findings from both the above studies have yet to be confirmed, preferably in larger studies with prospectively collected genomic Dna samples.
rCC risk has been evaluated in relation to a number of common genetic variants in leukocyte Dna (tables 4 and 5). most studies to date have identified a few genes in a pathway that might be relevant for renal carcinogenesis, and then used a candidate-gene approach to find single nucleotide polymorphisms (snPs) associated with disease. 16 most promising results have yet to be replicated in further investigations.
Genes encoding the glutathione S-transferase (Gst) enzymes, including GSTM1, GSTT1, and GSTP1, are the most studied in relation to rCC risk (table 4) . 128 Gst enzymes are active in the detoxification of polycyclic aromatic hydrocarbons in tobacco smoke, halogenated solvents, and other xenobiotics. Gst genes in general have not been statistically significantly associated with rCC risk, but genotype status has been shown to modify the associations between rCC and tobacco smoke, exposure to tCe or pesticides. Further investigation is needed to clarify these associations.
16
NAT2, which encodes N-acetyltransferase 2 and is involved in the metabolism of arylamine in tobacco smoke, has also been studied in relation to rCC. smoking-related risk of developing rCC was found to be higher among individuals carrying the slow acetylator NAT2 geno type, 129 consistent with observations in bladder cancer, 130 but this result has not yet been replicated.
vitamin D maintains calcium homeostasis and has been shown to have a role in inhibiting cell proliferation and progression in a number of cancers. 131 Genes in the vitamin D pathway have been investigated in relation to rCC risk, but findings are inconsistent across the few studies performed. 16 the most commonly examined vitamin D pathway gene encodes the vitamin D receptor (VDR), which mediates vitamin D activity and regulates transcription of other genes involved in cell growth and immunity. 132 a study that examined eight vitamin D pathway genes found increased rCC risk associated with variant haplotypes of VDR. 133 the same study also examined genes related to lipid peroxidation, blood pressure control, and cellular growth, differentiation, and apoptosis. [134] [135] [136] elevated rCC risk was associated with two snPs in the regulatory region of the apolipoprotein e gene, a result that was replicated in a second large study in the us. 134 elevated rCC risk was also observed with the apoptosis genes CASP1, CASP5, CASP4 and CASP12, and the blood pressure gene AGT, but replication is needed to confirm these findings (table 5) . 135, 136 High-throughput methods are being used for genomewide scanning of tagged snPs and copy number altera tions, and large collaborative studies involving a consortium of ongoing case-control and cohort studies of rCC are also underway. these efforts should accelerate the discovery of common genetic variations and elucidate how their interaction with environmental exposures might influence renal carcinogenesis.
Conclusions
worldwide kidney cancer incidence increased since the early 1970s, until the mid-1990s when it stabilized or declined in many countries. long-term data from Denmark and Connecticut show that an increase in kidney cancer incidence started as early as the 1930s. in the us, the incidence of rCC-the predominant subtype of kidney cancer-rose through the mid-2000s, while rates of rtCC have declined since the 1990s among both black and white populations. long-term worldwide data for kidney cancer subtypes are limited, but recent data from Denmark suggest that renal pelvis cancer incidence began to decline from the late 1980s. the decline in renal pelvis cancer, specifically rtCC, is likely to be due to the decrease in cigarette consumption in industrialized countries, although the removal of phenacetin from most markets around 1980 may also have contributed to the initial decline. most of the increase in detected rCC in the us since the 1980s has occurred for early-stage tumors, a pattern consistent with a downward shift in tumor stage and size, which has been observed in numerous clinical series. the rising prevalence of obesity and hypertension-well-established risk factors for rCC-is likely to have contributed to the increase in rCC incidence. another established risk factor, cigarette smoking, should have progressively less of a role in rCC development with decreasing consumption in developed countries, but might become more prominent in developing countries where smoking prevalence shows no sign of declining, and may even be increasing. accumulating evidence suggests that several other factors-physical activity, alcohol intake, occupational exposure to tCe, and high parity in women-affect rCC risk. the relative contribution of each of these risk factors to rCC incidence in a given population might vary, however, according to the presence of other risk and protective factors, awareness and control of predisposing conditions, and surveillance and incidental diagnosis of preclinical tumors. while only a small proportion of rCC occurs within the milieu of familial cancer syndromes, genetic susceptibility and its interaction with environmental exposure is believed to have
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The PubMed database was searched for articles published up to March 1, 2010. The MeSH search terms "kidney neoplasms" and "renal cell carcinoma" were used in combination with the subheadings "epidemiology", "trends", and "genetics", and other MeSH terms "risk factors", "incidence", "polymorphism, genetic" and "cohort studies", and MeSH terms for specific exposures, such as "hypertension", "obesity", and "occupations". Cohort studies and pooled analyses were selected for inclusion in this Review; case-control and other studies were also selected if they provided relevant information.
an etiologic role in the development of sporadic rCC. notably, however, studies of common genetic variants in rCC risk using candidate-gene approaches have yielded mixed results to date. the rapid advancement in laboratory technology for genome-wide scanning will allow more-thorough evaluation of common genetic variations. in conjunction with consortium efforts in pooling detailed exposure data and biological samples from welldesigned epidemiologic studies, these innovative technologies hold promise for enabling novel discoveries into the genetic determinants of rCC, and elucidating how interaction with environmental factors might influence rCC etiology.
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